Skip to content

Epidemiology of Injuries in Elite Badminton Players: a Prospective Study

Epidemiology of Injuries in Elite Badminton Players: a Prospective Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04181242
Acronym
BADINSEP
Enrollment
20
Registered
2019-11-29
Start date
2016-10-01
Completion date
2018-06-01
Last updated
2025-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sport Injury

Keywords

Epidemiology, Incidence, Athletic Injuries, Racquet Sports, Badminton

Brief summary

Objective: To determine the incidence and characteristics of injuries in elite badminton players over a competitive season. Design: 12-months prospective cohort study Setting: The French National Institute of Sport, Expertise, and Performance (INSEP). Participants: Twenty international elite badminton players Independent variables: The type, the location, the occurrence of the injury (match or training), the footwork type, the type of shot and the perceived fatigue were collected. Main Outcome Measures: Injury incidence rates were calculated per 1000 hours of play (Hop).

Interventions

None listed

Sponsors

University Hospital, Caen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Badminton players training at the at the French National Institute of Sport, Expertise, and Performance (INSEP) * Participant competing at an international level * Medical follow-up over the 12-months duration of the study

Exclusion criteria

* Participant unable to speak and read French language * Participant under the age of 18 * Lack of informed and signed consent

Design outcomes

Primary

MeasureTime frameDescription
Injury incidence ratesInjury incidence rates were calculated per 1000 hours of play (Hop) over the 12-month prospective follow-upInjury incidence rates were calculated per 1000 hours of play (Hop).

Secondary

MeasureTime frameDescription
Injury incidence rates according to disciplineInjury incidence rates were calculated per 1000 hours of play (Hop) over the 12-month prospective follow-upInjury incidence rates were calculated per 1000 hours of play (Hop) in singles and doubles players
Injury incidence rates according to occurenceInjury incidence rates were calculated per 1000 hours of play (Hop) over the 12-month prospective follow-upInjury incidence rates were calculated per 1000 hours of play (Hop) in match or training
Description of injuries according to location (on the body, n)Description of the number of injuries according to location of the injury on the body (n) over the 12-month prospective follow-upNumber of injuries according to location of the injury (on the body, n)
Injury incidence rates according to genderInjury incidence rates were calculated per 1000 hours of play (Hop) over the 12-month prospective follow-upInjury incidence rates were calculated per 1000 hours of play (Hop) in male and female
Description of injuries according to location (on the body, % of all)Description of the distribution of injuries according to location of the injury on the body (%) over the 12-month prospective follow-upDistribution of injuries according to location of the injury (on the body, % of all)
Description of injuries according to type of the injury (% of all)Description of the distribution of injuries according to the type of the injury (structure: muscle, tendon, bone, nerve...) (%) over the 12-month prospective follow-upDistribution of injuries according to type of the injury (% of all)
Description of injuries according to type of the injury (n)Description of injuries according to the type of the injury (structure: muscle, tendon, bone, nerve...) (n) over the 12-month prospective follow-upNumber of injuries according to type of the injury (n)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026